{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os, json\n",
    "\n",
    "import unstructured_client\n",
    "from unstructured_client.models import operations, shared\n",
    "\n",
    "client = unstructured_client.UnstructuredClient(\n",
    "    api_key_auth=os.getenv(\"UNSTRUCTURED_API_KEY\")\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os, json\n",
    "import unstructured_client\n",
    "from unstructured_client.models import operations, shared\n",
    "from unstructured_client.models.errors import SDKError\n",
    "from dotenv import load_dotenv\n",
    "load_dotenv()\n",
    "\n",
    "def get_elements_from_file(filename):\n",
    "    with open(filename, \"rb\") as f:          # pass bytes, not a file handle\n",
    "        file_bytes = f.read()\n",
    "            # print first 10 bytes\n",
    "\n",
    "    req = operations.PartitionRequest(\n",
    "        partition_parameters=shared.PartitionParameters(\n",
    "            strategy=shared.Strategy.FAST,\n",
    "            files=shared.Files(\n",
    "                content=file_bytes,\n",
    "                file_name=filename,\n",
    "                \n",
    "            ),\n",
    "            \n",
    "            languages=[\"heb\", \"eng\"],\n",
    "        )\n",
    "    )\n",
    "\n",
    "    client = unstructured_client.UnstructuredClient(\n",
    "        api_key_auth=os.getenv(\"UNSTRUCTURED_API_KEY\")\n",
    "    )\n",
    "\n",
    "    try:  \n",
    "        res = client.general.partition(request=req)\n",
    "        elements = res.elements                          # list of Element objects\n",
    "        \n",
    "        return elements\n",
    "    except SDKError as e:                                # friendlier error handling\n",
    "        print(f\"{e.status_code}: {e.message}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'2CuIov3dF0K9vnm1zu39yJa7QdYqNe'"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "os.getenv(\"UNSTRUCTURED_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [],
   "source": [
    "from pathlib import Path\n",
    "from typing import List\n",
    "\n",
    "from pathlib import Path\n",
    "from typing import List, Tuple\n",
    "\n",
    "def list_all_files(\n",
    "    start: str | Path,\n",
    "    exts: Tuple[str, ...] = (\".pdf\", \".doc\", \".docx\"),\n",
    ") -> List[str]:\n",
    "    \"\"\"\n",
    "    Return a list of full (absolute) paths for every *PDF, DOC, or DOCX* file\n",
    "    inside *start* and all its sub-directories.\n",
    "\n",
    "    Parameters\n",
    "    ----------\n",
    "    start : str | Path\n",
    "        The root folder to walk. Tilde (~) is expanded and the path is\n",
    "        resolved so the result is always absolute.\n",
    "    exts : tuple[str, ...], optional\n",
    "        File-name suffixes to include (case-insensitive). Default picks\n",
    "        '.pdf', '.doc', and '.docx'.\n",
    "\n",
    "    Raises\n",
    "    ------\n",
    "    FileNotFoundError\n",
    "        If *start* does not exist or is not a directory.\n",
    "    \"\"\"\n",
    "    root = Path(start).expanduser().resolve()\n",
    "\n",
    "    if not root.is_dir():\n",
    "        raise FileNotFoundError(f\"{root} is not an existing directory\")\n",
    "\n",
    "    # rglob('*') walks recursively; filter by suffix (case-insensitive)\n",
    "    return [\n",
    "        str(p)\n",
    "        for p in root.rglob(\"*\")\n",
    "        if p.is_file() and p.suffix.lower() in exts\n",
    "    ]\n",
    "\n",
    "\n",
    "pathes=list_all_files(\"docs\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/Users/matansharon/python/AI/unsructered/docs/ArtPrompt- ASCII Art-based Jailbreak Attacks against Aligned LLMs.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/GaLore- Memory-Efficient LLM Training by Gradient Low-Rank Projection.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/2403.06634.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Bonded Manifolds/obsolete/RMP - Bonded Manifolds - Rev B_scanned for TF.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Bonded Manifolds/obsolete/Risk Management Plan - Bonded Manifolds.doc\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Bonded Manifolds/obsolete/RMP - Bonded Manufolds - Rev A.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Bonded Manifolds/obsolete/RMF - bonded manifolds - Rev C.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Bonded Manifolds/obsolete/RMF- Bonded Manifolds -Rev G_scanned for TF.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Bonded Manifolds/obsolete/RMP - Bonded Manifolds.doc\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Bonded Manifolds/Production & Post Production Information/bonded manifolds -data 2021/סקר סיכונים הדבקת פלטות.docx\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Disposable PressureTransducer/obsolete/Risk Management Plan - Disposable Pressure Transducer.doc\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Disposable PressureTransducer/obsolete/RMP- Disposable Pressure Transducer modifications.doc\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Disposable PressureTransducer/obsolete/RMP - Transducer modifications - Rev A.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Disposable PressureTransducer/obsolete/RMF- DPT & DIPT Rev  C.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Disposable PressureTransducer/Production & post production information/data 2021/VCR#21-009 Kingstec.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Disposable PressureTransducer/Production & post production information/data 2021/VCRֳ#21-005 Kingstec.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Closed Stopcock & MRVLS/Obsolete/RMP - Closed Stopcock & MRVLS.doc\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Closed Stopcock & MRVLS/Obsolete/RMP - Closed Stopcock & MRVLS - Rev B_scanned for TF.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Closed Stopcock & MRVLS/Obsolete/General RMF - Closed Stopcock & MRVLS.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Closed Stopcock & MRVLS/Obsolete/Risk Management Plan - CSTP & MRVLS לא לשימוש.doc\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Closed Stopcock & MRVLS/Obsolete/RMF - closed STP - Rev E.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Closed Stopcock & MRVLS/Obsolete/RMF- Closed Stopcock - Rev H_scanned for TF.pdf\n",
      "/Users/matansharon/python/AI/unsructered/docs/Products/Closed Stopcock & MRVLS/Obsolete/RMP - Close STPs & MRVLS- Rev A.pdf\n"
     ]
    }
   ],
   "source": [
    "for path in pathes:\n",
    "    print(path)\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: GET https://api.unstructuredapp.io/general/docs \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n",
      "INFO: HTTP Request: POST https://api.unstructuredapp.io/general/v0/general \"HTTP/1.1 200 OK\"\n"
     ]
    }
   ],
   "source": [
    "unstructerd_files=[]\n",
    "for i in range(len(pathes)):\n",
    "    el=get_elements_from_file(pathes[i])\n",
    "    unstructerd_files.append(el)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "23"
      ]
     },
     "execution_count": 76,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>type</th>\n",
       "      <th>element_id</th>\n",
       "      <th>text</th>\n",
       "      <th>metadata</th>\n",
       "      <th>filename</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "Empty DataFrame\n",
       "Columns: [type, element_id, text, metadata, filename]\n",
       "Index: []"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import pandas as pd\n",
    "cols=['type','element_id','text','metadata','filename']\n",
    "df=pd.DataFrame(columns=cols)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [],
   "source": [
    "rows_list = []\n",
    "for element in unstructerd_files:\n",
    "    for row in element:\n",
    "        rows_list.append({\n",
    "            'type': row['type'],\n",
    "            'filename': row['metadata']['filename'],\n",
    "            'element_id': row['element_id'],\n",
    "            'text': row['text'],\n",
    "            'metadata': row['metadata']\n",
    "        })\n",
    "unstructerd_df = pd.DataFrame(rows_list, columns=cols)\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "3221"
      ]
     },
     "execution_count": 77,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(unstructerd_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Duplicate text found in row 0: 3-01-21  SOP 4  Appendix Appendix status - released Revision  5 Valid from ‏25/12/2016 Product/s name Bonded Manifolds Document status Under Edit Author - Title Revision B Risk Management Plan Release Date - Document# Doc-075384 Page 8 of 8\n",
      "Duplicate text found in row 1: Company: Elcam Medical\n",
      "Duplicate text found in row 2: Product Description:\n",
      "Duplicate text found in row 3: The Bonded Manifolds family of products contains products that are alternative for Manifold-Monoblocks. They are 2,3 and 4 gang UV bonded manifold, LB and closed stopcocks.  \n",
      "Duplicate text found in row 4: This Risk management plan covers all risk management activities required for bonded manifolds development projects as well as their design change projects.\n",
      "Duplicate text found in row 5: Their lifecycle stages of such projects are divided to:\n",
      "Duplicate text found in row 6: project initiation\n",
      "Duplicate text found in row 7: Design Planning\n",
      "Duplicate text found in row 8: Design Input\n",
      "Duplicate text found in row 9: Design Output\n",
      "Duplicate text found in row 10: Design Verification & Validation\n",
      "Duplicate text found in row 11: Process Validation\n",
      "Duplicate text found in row 12: Transfer to production\n",
      "Duplicate text found in row 13: Production & Post marketing.\n",
      "Duplicate text found in row 14: First Risk review meeting shall be performed after Design Input and before Design V&V. Risk Management activities are categorized as Design Review Activities along the project\n",
      "Duplicate text found in row 15: Purpose:\n",
      "Duplicate text found in row 16: The purpose of this document is planning the risk management process for the Bonded Manifold family of products.\n",
      "Duplicate text found in row 17: Definitions:\n",
      "Duplicate text found in row 18: FMEA: Failure Mode and Effect Analysis.\n",
      "Duplicate text found in row 19: Harm: physical injury or damage to the health of people, or damage to property or the environment.\n",
      "Duplicate text found in row 20: Hazard: potential source of harm. \n",
      "Duplicate text found in row 21: Hazardous situation: circumstances in which people, property, or the environment are exposed to one or more hazard(s).\n",
      "Duplicate text found in row 22: Risk: combination of the probability of occurrence of harm and the severity of that harm.\n",
      "Duplicate text found in row 23: RPN: Risk Priority number\n",
      "Duplicate text found in row 24: ALARP:  As Low As Reasonably Possible.\n",
      "Duplicate text found in row 25: AFAP:  As Far as Possible.\n",
      "Duplicate text found in row 26: Method:\n",
      "Duplicate text found in row 27: 4.1. Risk Management Process description:\n",
      "Duplicate text found in row 28: Risk Management process will be performed as required by ISO 14971:2007 and BS EN ISO 14971:2012, (\"Medical Devices – Application of risk management to medical devices\") and in accordance with Elcam's SOP# 03-01-21.\n",
      "Duplicate text found in row 29: The process will include Risk Analysis, Risk Evaluation and Risk Control and at the end of the process also Production & Post Production information.\n",
      "Duplicate text found in row 30: (The method for risk analysis and evaluation to be used is mainly FMEA (Fail Mode & Effect Analysis). Other techniques will be used as well when needed. \n",
      "Duplicate text found in row 31: The emphasis will be on risks primarily to the patient, but also to the operator, other persons, other equipment and the environment occurs during the product shelf life and/or in-use life. Risks which effect Elcam's image or Elcam's manufacturing facilities that do not affect product's safety or performance are not included within this Risk Management Process.\n",
      "Duplicate text found in row 32: 4.1.1. Risk Analysis:\n",
      "Duplicate text found in row 33: First step is listing the intended use or purpose of the product and its characteristics related to its safety. \n",
      "Duplicate text found in row 34: Then, identifying the known or foreseeable hazards and hazardous situations in normal and fault conditions, their causes and estimating the risks for each hazardous situation. This identification will initially be performed by a review meeting after design Input phase, after establishing the Device Requirements and the Product Specifications. \n",
      "Duplicate text found in row 35: 4.1.2. Risk Evaluation:\n",
      "Duplicate text found in row 36: The identified hazardous situations are evaluated for their risk probability of occurrence (P), severity (S) and detectability (D) according to the scales described below. Afterwards the RPN number is calculated by multiplying the ratings for each hazard and the acceptability is determined according to the acceptance criteria. \n",
      "Duplicate text found in row 37: Each parameter (P, S, or D) will be analyzed in order to rank and estimate the risk: \n",
      "Duplicate text found in row 38: Probability of occurrence (P):  \n",
      "Duplicate text found in row 39: Value Probability for occurrence Verbal description for probability 1 Less than 1 in 1,000,000 Evidence that will not occur 2 1:100,000 - 1:1,000,000 Low probability, rare occurrence 4 1:100,000 - 1:10,000 Will occur several times 6 1:100 - 1:10,000 Will occur several times 8 More than 1:100 High probability, likely to occur frequently\n",
      "Duplicate text found in row 40: Degree of Severity (S): \n",
      "Duplicate text found in row 41: S Rating Severity Severity to Patient/User Severity to Elcam Severity to Manufacture 1 Minor All is fine up to small discomfort, minor damage in performance. All is fine up to deviations in spec border. Small effect on equipment or product, a few production hours loss. 2 Medium Degradation in performance without harm. Damage to image, do not meet spec. Degradation in equipment or its operation small effect on product in non-functional characters, a few days loss. 4 Severe The part does not function but does not cause harm. Need to replace parts, severe impact to image, will not meet fundamental characteristic in spec. Medium degradation in equipment or its operation affecting product in non-functional characters, two-three weeks loss. 6 Severe - critical The product does not function and causes injury or condition requiring medical treatment. Severe impact to image, product will not meet the requirements of spec, market loss. High deterioration in equipment or its operation severely affecting production or product functionality, several week losses. 8 Critical Severe harm to patient: death, irreversible injury or condition or long term medical aid. Low suit, market loss. Severe damage to equipment, not being able to produce at all or producing non-functional products, loss of more than month and a half.\n",
      "Duplicate text found in row 42: Rate according to severity to patient/user or their environment. If the risk has an effect on several fields (patient/user and/or Elcam and/or Manufacture) rate according to the worst of all.\n",
      "Duplicate text found in row 43: Degree of Detectability (D): \n",
      "Duplicate text found in row 44: D Rating Defect Detection 1 Defect, if occurred, will always be detected at Elcam during production. 2 Defect, if occurred, will occasionally be detected at Elcam during production. 3 Defects, if occurred, will rarely be detected at Elcam or Will be detected by customer (not end user). 4 Defects, if occurred, will not be detected at Elcam. It will always be detected by the end user.\n",
      "Duplicate text found in row 45: RPN calculation:\n",
      "Duplicate text found in row 46: The calculation of the Risk Priority Number (RPN) is done by multiplying the risk analysis values:            (S x P) or (S x P x D).\n",
      "Duplicate text found in row 47: According to the calculated RPN value the priority for mitigation is determined (Risk Priority Level). \n",
      "Duplicate text found in row 48: Risk Priority Levels:\n",
      "Duplicate text found in row 49: (S*P) value Color Risk priority Level (S*P)≤8 (Green) Low 8<(S*P)<32 (Yellow) Medium (ALARP/AFAP*) 32≤(S*P) (Red) High\n",
      "Duplicate text found in row 50: Or\n",
      "Duplicate text found in row 51: (S*P*D) value Color Risk Priority Level (S*P*D)≤8 (Green) Low 8<(S*P*D)≤32 (Yellow) Medium (ALARP/AFAP*) 32<(S*P*D) (Red) High\n",
      "Duplicate text found in row 52: Green area – Low rated risks.\n",
      "Duplicate text found in row 53: Yellow area – Medium rated risks. \n",
      "Duplicate text found in row 54: Risks in the ALARP/AFAP area (ALARP is according to definition of ISO 14971:2007 AFAP is according to definition in BS EN ISO 14971:2012). Acceptable but require additional controls and monitoring. There should be actions to reduce them further and they require periodical review.\n",
      "Duplicate text found in row 55: Red area – High rated risk, additional actions should be taken to reduce this risk. \n",
      "Duplicate text found in row 56: 4.1.3. Risk Control:\n",
      "Duplicate text found in row 57: For each risk, whether marked in green, yellow or red, Risk Control measures should be taken in order to reduce the severity of the harm or reduce the probability of its occurrence.\n",
      "Duplicate text found in row 58: The risk control measures should be one or more of the following options in the priority order listed:\n",
      "Duplicate text found in row 59: Inherent safety by design\n",
      "Duplicate text found in row 60: Protective measures in the product itself or in the manufacturing process.\n",
      "Duplicate text found in row 61: Information for safety\n",
      "Duplicate text found in row 62: Risk Control includes defining the measures to be taken in order to reduce the risks, Implementation of the risk control measures and verification of their implementation and their effectiveness, Residual Risk Evaluation after the Implementation. If measures are not practical Risk to Benefit Analysis should be made in order to demonstrate whether the products` benefits outweigh the residual risk. Risks arising from the risk control measures should be identified as well.\n",
      "Duplicate text found in row 63: At the end of the risk control measures, the Acceptability of the Overall Residual Risk is to be documented. \n",
      "Duplicate text found in row 64: 4.1.4. Production & Post-production Information:\n",
      "Duplicate text found in row 65: After the end of the development phase, for each family of products, the risks should be reviewed according to information gained from the production of the device and afterwards information after the device is being sent to customers (customers' feedback and satisfaction, complaints, information from users, operators etc.). This information shall be evaluated to identify any unrecognized hazards and hazardous situations and to evaluate acceptability of risks that were identified previously.\n",
      "Duplicate text found in row 66: 4.2. Verification plan\n",
      "Duplicate text found in row 67: After each important phase during product lifecycle a risk review meeting is to be performed (Initial risk review meeting: after Design Input).\n",
      "Duplicate text found in row 68: The Risk Analysis, Evaluation and Control activities are to be initially identified by a review meeting attending represents of all relevant departments (R&D, Manufacturing Eng, QA, Marketing, production etc. including someone not directly involved in the project or product).\n",
      "Duplicate text found in row 69: Reviews in order to verify that mitigation activities were performed and assessment of their effectiveness are to be performed by the person in charge of risk management from QA and the project manager.\n",
      "Duplicate text found in row 70: Overall residual risks acceptability and Risk to benefit analysis is also to be performed by QA and project manager.\n",
      "Duplicate text found in row 71: Other risk reviews in order to view the pre-identified hazards, risks, their evaluations and their relevance and to identify new hazards will be performed in a risk review meeting with representatives of all relevant departments.\n",
      "Duplicate text found in row 72: 4.3. Allocation of responsibilities:\n",
      "Duplicate text found in row 73: 4.3.1. Responsibility for assuring that the risk management activities are done is by the Project Manager.\n",
      "Duplicate text found in row 74: 4.3.2. Person In charge for Risk Management activities execution: Quality Engineer in R&D.\n",
      "Duplicate text found in row 75: 4.3.3. Responsibility of assuring that Risk Control activities are done as indicated in the Risk Management File is by the project manager.\n",
      "Duplicate text found in row 76: 4.3.4. Risk Control measures are to be performed as indicated in the Risk Management File by the people mentioned there.\n",
      "Duplicate text found in row 77: 4.3.5. Responsibility for Production & Post Production Information gathering & analyzing is Quality Engineer in R&D.\n",
      "Duplicate text found in row 78: Documenting Risk Management Process\n",
      "Duplicate text found in row 79: The Risk Management Process will be documented in the product's Design History File (DHF).  It will be according to the format specified in Appendix 5 of SOP#3-01-21. The risk management file will be managed as a controlled document, revised with the progression of the risk management process and all its revisions will be kept for process tracking in the design history file.\n",
      "Duplicate text found in row 80: Risk general management documents related to production and post production stages will be documented separately afterwards in \"Risk Management\" folder at the EPDM system.\n",
      "Duplicate text found in row 81: Summary\n",
      "Duplicate text found in row 82: This document outlines the risk management activities for Bonded Manifold family of products. It determines the scales of rating them and the acceptance criteria. It also determines the means of reviewing and verifying them and the responsibilities. The product lifecycle stages in which this plan is applicable are as described in the scope.\n",
      "Duplicate text found in row 83: Document Revision Control:\n",
      "Duplicate text found in row 84: Revision History Tracking: Date: Revision 0- first version 5-July-2012 Revision A – update of referenced standards and definition of ALARP/AFAP in addition to Change of format and also having this document general for all customers. 16-Mar-2014 Revision B – Updating document format; Adding to section 1 timing along product lifecycle for risk management activities; Moving the definitions of ALARP and AFAP to section 3; Updating Risk evaluation definitions in section 4.1.2. according to the new version of annexes 5, 7 and 8 of SOP 3-01-21.; Adding guidance on severity rating; Adding clarification regarding the risk control (should be performed for all risks); Updating location of general risk documents (in the EPDM system); and Correcting duplicate of sections 4.3 \"Responsibilities\" and 4.3. \"Allocation of responsibilities\". 27-Dec-2016\n",
      "Duplicate text found in row 85: Review and approval:\n",
      "Duplicate text found in row 86: Written by: Name Date Signature QA Eng. - - -\n",
      "Duplicate text found in row 87: Reviewed & Approved by: Name Date Signature R&D Director /VP - - - VP of QA & RA/ QA Manager R&D - - -\n",
      "Duplicate text found in row 88: SOP 3-01-21 4  Appendix Appendix status - released Revision  7 Valid from ‏20/04/2017 Product/s name Disposable Pressure Transducer Document status Under Edit Author - Title Revision C Risk Management Plan Release Date - Document# Doc-081938 Page 7 of 7\n",
      "Duplicate text found in row 89: Company: Elcam Medical\n",
      "Duplicate text found in row 90: Product Description:\n",
      "Duplicate text found in row 91: The DPT (Disposable Pressure Transducer) is a product used for arterial blood pressure sensing. There are two versions DIPT (Integrated DPT) and DPT (also called DSPT -Straight DPT).\n",
      "Duplicate text found in row 92: This Risk management plan covers all risk management activities required for the design change projects of the high pressure stopcocks.\n",
      "Duplicate text found in row 93: Projects lifecycles are usually divided to:\n",
      "Duplicate text found in row 94: project initiation\n",
      "Duplicate text found in row 95: Design Planning\n",
      "Duplicate text found in row 96: Design Input\n",
      "Duplicate text found in row 97: Design Output\n",
      "Duplicate text found in row 98: Design Verification & Validation (V&V)\n",
      "Duplicate text found in row 99: Process Validation\n",
      "Duplicate text found in row 100: Transfer to production\n",
      "Duplicate text found in row 101: Production and post marketing\n",
      "Duplicate text found in row 102: First Risk review meeting is to be performed after Design Input and before Design V&V. Risk Management activities are categorized as Design Review Activities along the project.\n",
      "Duplicate text found in row 103: Purpose:\n",
      "Duplicate text found in row 104: The purpose of this document is planning the risk management process for the Disposable Pressure Transducer family of products.\n",
      "Duplicate text found in row 105: Definitions:\n",
      "Duplicate text found in row 106: FMEA: Failure Mode and Effect Analysis.\n",
      "Duplicate text found in row 107: Harm: physical injury or damage to the health of people, or damage to property or the environment.\n",
      "Duplicate text found in row 108: Hazard: potential source of harm. \n",
      "Duplicate text found in row 109: Hazardous situation: circumstances in which people, property, or the environment are exposed to one or more hazard(s).\n",
      "Duplicate text found in row 110: Risk: combination of the probability of occurrence of harm and the severity of that harm.\n",
      "Duplicate text found in row 111: RPN: Risk Priority number, Multiply of Severity*Probability*Detectability.\n",
      "Duplicate text found in row 112: ALARP:  As Low As Reasonably Possible.\n",
      "Duplicate text found in row 113: AFAP:  As Far as Possible.\n",
      "Duplicate text found in row 114: Method:\n",
      "Duplicate text found in row 115: 4.1. Risk Management Process description:\n",
      "Duplicate text found in row 116: Risk Management process will be performed as required by ISO 14971:2007 and BS EN ISO 14971:2012, (\"Medical Devices – Application of risk management to medical devices\") and in accordance with Elcam's SOP# 03-01-21.\n",
      "Duplicate text found in row 117: The process will include Risk Analysis, Risk Evaluation and Risk Control and at the end of the process also Production & Post Production information.\n",
      "Duplicate text found in row 118: (The method for risk analysis and evaluation to be used is mainly FMEA (Fail Mode & Effect Analysis). Other techniques will be used as well when needed. \n",
      "Duplicate text found in row 119: The emphasis will be on risks primarily to the patient, but also to the operator, other persons, other equipment and the environment occurs during the product shelf life and/or in-use life. Risks which effect Elcam's image or Elcam's manufacturing facilities that do not affect product's safety or performance are not included within this Risk Management Process.\n",
      "Duplicate text found in row 120: 4.1.1. Risk Analysis:\n",
      "Duplicate text found in row 121: First step is listing the intended use or purpose of the product and its characteristics related to its safety. \n",
      "Duplicate text found in row 122: Then, identifying the known or foreseeable hazards and hazardous situations in normal and fault conditions, their causes and estimating the risks for each hazardous situation. This identification will initially be performed by a review meeting after design Input phase, after establishing the Device Requirements and the Product Specifications. \n",
      "Duplicate text found in row 123: 4.1.2. Risk Evaluation:\n",
      "Duplicate text found in row 124: The identified hazardous situations are evaluated for their risk probability of occurrence (P), severity (S) and detectability (D) according to the scales described below. Afterwards the RPN number is calculated by multiplying the ratings for each hazard and the acceptability is determined according to the acceptance criteria. \n",
      "Duplicate text found in row 125: Each parameter (P, S, or D) will be analyzed in order to rank and estimate the risk: \n",
      "Duplicate text found in row 126: Probability of occurrence (P):  \n",
      "Duplicate text found in row 127: Value Probability for occurrence Verbal description for probability 1 Less than 1 in 1,000,000 Evidence that will not occur 2 1:10,000 - 1:1,000,000 Low probability, rare occurrence 4 1:1,000 - 1:10,000 Will occur several times 6 1:100 - 1:1,000 Will occur several times, often 8 More than 1:100 High probability, likely to occur frequently\n",
      "Duplicate text found in row 128: Degree of Severity (S): \n",
      "Duplicate text found in row 129: S Rating Severity Severity to Patient/User Severity to Elcam Severity to Manufacture 1 Minor All is fine up to small discomfort, minor damage in performance. All is fine up to deviations in spec border. Small effect on equipment or product, a few production hours loss. 2 Medium Degradation in performance without harm. Damage to image, do not meet spec. Degradation in equipment or its operation small effect on product in non-functional characters, a few days loss. 4 Severe The part does not function but does not cause harm. Need to replace parts, severe impact to image, will not meet fundamental characteristic in spec. Medium degradation in equipment or its operation affecting product in non-functional characters, two-three weeks loss. 6 Severe - critical The product does not function and causes injury or condition requiring medical treatment. Severe impact to image, product will not meet the requirements of spec, market loss. High deterioration in equipment or its operation severely affecting production or product functionality, several week losses. 8 Critical Severe harm to patient: death, irreversible injury or condition or long term medical aid. Low suit, market loss. Severe damage to equipment, not being able to produce at all or producing non-functional products, loss of more than month and a half.\n",
      "Duplicate text found in row 130: Rate according to severity to patient/user or their environment. If the risk has an effect on several fields (patient/user and/or Elcam and/or Manufacture) rate according to the worst of all.\n",
      "Duplicate text found in row 131: Degree of Detectability (D) – Relevant mainly to Process risks: \n",
      "Duplicate text found in row 132: D Rating Defect Detection 1 Defect, if occurred, will always be detected at Elcam during production. 2 Defect, if occurred, will occasionally be detected at Elcam during production. 3 Defects, if occurred, will rarely be detected at Elcam or Will be detected by customer (not end user). 4 Defects, if occurred, will not be detected at Elcam. It will always be detected by the end user.\n",
      "Duplicate text found in row 133: RPN calculation:\n",
      "Duplicate text found in row 134: The calculation of the Risk Priority Number (RPN) is done by multiplying the risk values:         (S x P) or (S x P x D).\n",
      "Duplicate text found in row 135: According to the calculated RPN value the priority for mitigation is determined (Risk Priority Level). \n",
      "Duplicate text found in row 136: Risk Priority Levels:\n",
      "Duplicate text found in row 137: (S*P) value Color Risk priority Level (S*P)≤8 (Green) Low 8<(S*P) ≤32 (Yellow) Medium (ALARP/AFAP*) 32< (S*P) (Red) High\n",
      "Duplicate text found in row 138: Or\n",
      "Duplicate text found in row 139: (S*P*D) value Color Risk Priority Level (S*P*D)≤8 (Green) Low 8<(S*P*D)≤32 (Yellow) Medium (ALARP/AFAP*) 32<(S*P*D) (Red) High\n",
      "Duplicate text found in row 140: Green area – Low rated risks.\n",
      "Duplicate text found in row 141: Yellow area – Medium rated risks. \n",
      "Duplicate text found in row 142: Risks in the ALARP/AFAP area (ALARP is according to definition of ISO 14971:2007 AFAP is according to definition in BS EN ISO 14971:2012). Acceptable but require additional controls and monitoring. There should be actions to reduce them further and they require periodical review.\n",
      "Duplicate text found in row 143: Red area – High rated risk, additional actions should be taken to reduce this risk. \n",
      "Duplicate text found in row 144: 4.1.3. Risk Control:\n",
      "Duplicate text found in row 145: For each risk, whether marked in green, yellow or red, Risk Control measures should be taken in order to reduce the severity of the harm or reduce the probability of its occurrence.\n",
      "Duplicate text found in row 146: The risk control measures should be one or more of the following options in the priority order listed:\n",
      "Duplicate text found in row 147: Inherent safety by design\n",
      "Duplicate text found in row 148: Protective measures in the product itself or in the manufacturing process.\n",
      "Duplicate text found in row 149: Information for safety\n",
      "Duplicate text found in row 150: Risk Control includes defining the measures to be taken in order to reduce the risks, Implementation of the risk control measures and verification of their implementation and their effectiveness, Residual Risk Evaluation after the Implementation. If measures are not practical Risk to Benefit Analysis should be made in order to demonstrate whether the products` benefits outweigh the residual risk. Risks arising from the risk control measures should be identified as well.\n",
      "Duplicate text found in row 151: At the end of the risk control measures, the Acceptability of the Overall Residual Risk is to be documented. \n",
      "Duplicate text found in row 152: 4.1.4. Production & Post-production Information:\n",
      "Duplicate text found in row 153: After the end of the development phase, for each family of products, the risks should be reviewed according to information gained from the production of the device and afterwards information after the device is being sent to customers (customers' feedback and satisfaction, complaints, information from users, operators etc.). This information shall be evaluated to identify any unrecognized hazards and hazardous situations and to evaluate acceptability of risks that were identified previously.\n",
      "Duplicate text found in row 154: 4.2. Verification plan\n",
      "Duplicate text found in row 155: After each important phase during product lifecycle a risk review meeting is to be performed (Initial risk review meeting: after Design Input).\n",
      "Duplicate text found in row 156: The Risk Analysis, Evaluation and Control activities are to be initially identified by a review meeting attending represents of all relevant departments (R&D, Manufacturing Eng, QA, Marketing, production etc. including someone not directly involved in the project or product).\n",
      "Duplicate text found in row 157: Reviews in order to verify that mitigation activities were performed and assessment of their effectiveness are to be performed by the person in charge of risk management from QA and the project manager.\n",
      "Duplicate text found in row 158: Overall residual risks acceptability and Risk to benefit analysis is also to be performed by QA and project manager.\n",
      "Duplicate text found in row 159: Other risk reviews in order to view the pre-identified hazards, risks, their evaluations and their relevance and to identify new hazards will be performed in a risk review meeting with representatives of all relevant departments.\n",
      "Duplicate text found in row 160: 4.3. Allocation of responsibilities:\n",
      "Duplicate text found in row 161: 4.3.1. Responsibility for assuring that the risk management activities are done is by the Project Manager.\n",
      "Duplicate text found in row 162: 4.3.2. Person In charge for Risk Management activities execution: Quality Engineer in R&D.\n",
      "Duplicate text found in row 163: 4.3.3. Responsibility of assuring that Risk Control activities are done as indicated in the Risk Management File is by the project manager.\n",
      "Duplicate text found in row 164: 4.3.4. Risk Control measures are to be performed as indicated in the Risk Management File by the people mentioned there.\n",
      "Duplicate text found in row 165: 4.3.5. Responsibility for Production & Post Production Information gathering & analyzing is Quality Engineer in R&D.\n",
      "Duplicate text found in row 166: Documenting Risk Management Process\n",
      "Duplicate text found in row 167: The Risk Management Process will be documented in the product's Design History File (DHF).  It will be according to the format specified in Appendix 5 or 8 of SOP#3-01-21. The risk management file will be managed as a controlled document, revised with the progression of the risk management process and all its revisions will be kept for process tracking in the design history file.\n",
      "Duplicate text found in row 168: General Risk management documents (for family of products) related to production and post production stages will be documented separately afterwards in \"Risk Management\" folder at the EPDM system and using appendix 7 of SOP 3-01-21. \n",
      "Duplicate text found in row 169: Summary\n",
      "Duplicate text found in row 170: This document outlines the risk management activities for the Disposable Pressure Transducer family of products. It determines the scales of rating them and the Risk Priority Levels. It also determines the means of reviewing and verifying them and the responsibilities. The product lifecycle stages in which this plan is applicable are as described in the scope.\n",
      "Duplicate text found in row 171: Document Revision Control:\n",
      "Duplicate text found in row 172: Revision History Tracking: Date: Revision 0- first release 19-Nov-2008 Revision A - Overall review and updates 30-Dec-2014 Revision B - Updating document format. Adding definitions of ALARP and AFAP to section 3. Updating Risk evaluation definitions in section 4.1.2.according to the new version of annexes 5, 7 and 8 of SOP 3-01-21. Adding guidance on severity rating; Adding clarification regarding the risk control (should be performed for all risks) and Updating location of general risk documents (in the EPDM system). 12-Jan-2017 Revision C - Correcting Probability scales and Risk Priority Levels according latest version of Appendix 5, 7 and 8 of SOP 3-01-21. Adding guidance for using appendix 5, 7 and 8 of SOP 3-01-21 to \"Documenting Risk Management Process\" section. 16-Aug-2017\n",
      "Duplicate text found in row 173: Review and approval:\n",
      "Duplicate text found in row 174: Written by: Name Date Signature QA Eng. - - -\n",
      "Duplicate text found in row 175: Reviewed & Approved by: Name Date Signature Chief Technology Officer /R&D Manager - - - Chief Quality & RA Officer/ QA Manager R&D - - -\n",
      "Duplicate text found in row 176: 3-01-21  SOP 4  Appendix Appendix status - released Revision  5 Valid from ‏25/12/2016 Product/s name - Document status Under Edit Author - Title Revision B Risk Management Plan Release Date - Document# Doc-076035 Page 7 of 7\n",
      "Duplicate text found in row 177: Company: Elcam Medical\n",
      "Duplicate text found in row 178: Product Description:\n",
      "Duplicate text found in row 179: The DPT (Disposable Pressure Transducer) is a product used for arterial blood pressure sensing. There are two versions DIPT (Integrated DPT) and DPT (also called DSPT -Straight DPT).\n",
      "Duplicate text found in row 180: This Risk management plan covers all risk management activities required for the design change projects of the high pressure stopcocks.\n",
      "Duplicate text found in row 181: Projects lifecycles are usually divided to:\n",
      "Duplicate text found in row 182: project initiation\n",
      "Duplicate text found in row 183: Design Planning\n",
      "Duplicate text found in row 184: Design Input\n",
      "Duplicate text found in row 185: Design Output\n",
      "Duplicate text found in row 186: Design Verification & Validation (V&V)\n",
      "Duplicate text found in row 187: Process Validation\n",
      "Duplicate text found in row 188: Transfer to production\n",
      "Duplicate text found in row 189: Production and post marketing\n",
      "Duplicate text found in row 190: First Risk review meeting is to be performed after Design Input and before Design V&V. Risk Management activities are categorized as Design Review Activities along the project.\n",
      "Duplicate text found in row 191: Purpose:\n",
      "Duplicate text found in row 192: The purpose of this document is planning the risk management process for the Disposable Pressure Transducer modifications.\n",
      "Duplicate text found in row 193: Definitions:\n",
      "Duplicate text found in row 194: FMEA: Failure Mode and Effect Analysis.\n",
      "Duplicate text found in row 195: Harm: physical injury or damage to the health of people, or damage to property or the environment.\n",
      "Duplicate text found in row 196: Hazard: potential source of harm. \n",
      "Duplicate text found in row 197: Hazardous situation: circumstances in which people, property, or the environment are exposed to one or more hazard(s).\n",
      "Duplicate text found in row 198: Risk: combination of the probability of occurrence of harm and the severity of that harm.\n",
      "Duplicate text found in row 199: RPN: Risk Priority number, Multiply of Severity*Probability*Detectability.\n",
      "Duplicate text found in row 200: ALARP:  As Low As Reasonably Possible.\n",
      "Duplicate text found in row 201: AFAP:  As Far as Possible.\n",
      "Duplicate text found in row 202: Method:\n",
      "Duplicate text found in row 203: Risk Management Process description:\n",
      "Duplicate text found in row 204: Risk Management process will be performed as required by ISO 14971:2007 and BS EN ISO 14971:2012, (\"Medical Devices – Application of risk management to medical devices\") and in accordance with Elcam's SOP# 03-01-21.\n",
      "Duplicate text found in row 205: Method description \n",
      "Duplicate text found in row 206: The process will include Risk Analysis, Risk Evaluation and Risk Control and at the end of the process also Production & Post Production information.\n",
      "Duplicate text found in row 207: The method for risk analysis and evaluation to be used is mainly FMEA (Fail Mode & Effect Analysis). Other techniques will be used as well when needed. \n",
      "Duplicate text found in row 208: The emphasis will be on risks primarily to the patient, but also to the operator, other persons, other equipment and the environment occurs during the product shelf life and/or in-use life. Risks which effect Elcam's image or Elcam's manufacturing facilities that do not affect product's safety or performance are not included within this Risk Management Process.\n",
      "Duplicate text found in row 209: Risk Analysis:\n",
      "Duplicate text found in row 210: First step is listing the intended use or purpose of the product and its characteristics related to its safety. \n",
      "Duplicate text found in row 211: Then, identifying the known or foreseeable hazards and hazardous situations in normal and fault conditions, their causes and estimating the risks for each hazardous situation. This identification will initially be performed by a review meeting after design Input phase, after establishing the Device Requirements and the Product Specifications. \n",
      "Duplicate text found in row 212: Risk Evaluation:\n",
      "Duplicate text found in row 213: The identified hazardous situations are evaluated for their risk probability of occurrence (P), severity (S) and detectability (D) according to the scales described below. Afterwards the RPN number is calculated by multiplying the ratings for each hazard and the acceptability is determined according to the acceptance criteria. \n",
      "Duplicate text found in row 214: Each parameter (P, S, or D) will be analyzed in order to rank and estimate the risk: \n",
      "Duplicate text found in row 215: Probability of occurrence (P):  \n",
      "Duplicate text found in row 216: Value Probability for occurrence Verbal description for probability 1 Less than 1 in 1,000,000 Evidence that will not occur 2 1:100,000 - 1:1,000,000 Low probability, rare occurrence 4 1:100,000 - 1:10,000 Will occur several times 6 1:100 - 1:10,000 Will occur several times 8 More than 1:100 High probability, likely to occur frequently\n",
      "Duplicate text found in row 217: Degree of Severity (S): \n",
      "Duplicate text found in row 218: S Rating Severity Severity to Patient/User Severity to Elcam Severity to Manufacture 1 Minor All is fine up to small discomfort, minor damage in performance. All is fine up to deviations in spec border. Small effect on equipment or product, a few production hours loss. 2 Medium Degradation in performance without harm. Damage to image, do not meet spec. Degradation in equipment or its operation small effect on product in non-functional characters, a few days loss. 4 Severe The part does not function but does not cause harm. Need to replace parts, severe impact to image, will not meet fundamental characteristic in spec. Medium degradation in equipment or its operation affecting product in non-functional characters, two-three weeks loss. 6 Severe - critical The product does not function and causes injury or condition requiring medical treatment. Severe impact to image, product will not meet the requirements of spec, market loss. High deterioration in equipment or its operation severely affecting production or product functionality, several week losses. 8 Critical Severe harm to patient: death, irreversible injury or condition or long term medical aid. Low suit, market loss. Severe damage to equipment, not being able to produce at all or producing non-functional products, loss of more than month and a half.\n",
      "Duplicate text found in row 219: Rate according to severity to patient/user or their environment. If the risk has an effect on several fields (patient/user and/or Elcam and/or Manufacture) rate according to the worst of all.\n",
      "Duplicate text found in row 220: Degree of Detectability (D) – Relevant mainly to Process risks: \n",
      "Duplicate text found in row 221: D Rating Defect Detection 1 Defect, if occurred, will always be detected at Elcam during production. 2 Defect, if occurred, will occasionally be detected at Elcam during production. 3 Defects, if occurred, will rarely be detected at Elcam or Will be detected by customer (not end user). 4 Defects, if occurred, will not be detected at Elcam. It will always be detected by the end user.\n",
      "Duplicate text found in row 222: RPN calculation:\n",
      "Duplicate text found in row 223: The calculation of the Risk Priority Number (RPN) is done by multiplying the risk values:         (S x P) or (S x P x D).\n",
      "Duplicate text found in row 224: According to the calculated RPN value the priority for mitigation is determined (Risk Priority Level). \n",
      "Duplicate text found in row 225: Risk Priority Levels:\n",
      "Duplicate text found in row 226: (S*P) value Color Risk priority Level (S*P)≤8 (Green) Low 8<(S*P)<32 (Yellow) Medium (ALARP/AFAP*) 32≤(S*P) (Red) High\n",
      "Duplicate text found in row 227: Or\n",
      "Duplicate text found in row 228: (S*P*D) value Color Risk Priority Level (S*P*D)≤8 (Green) Low 8<(S*P*D)≤32 (Yellow) Medium (ALARP/AFAP*) 32<(S*P*D) (Red) High\n",
      "Duplicate text found in row 229: Green area – Low rated risks.\n",
      "Duplicate text found in row 230: Yellow area – Medium rated risks. \n",
      "Duplicate text found in row 231: Risks in the ALARP/AFAP area (ALARP is according to definition of ISO 14971:2007 AFAP is according to definition in BS EN ISO 14971:2012). Acceptable but require additional controls and monitoring. There should be actions to reduce them further and they require periodical review.\n",
      "Duplicate text found in row 232: Red area – High rated risk, additional actions should be taken to reduce this risk. \n",
      "Duplicate text found in row 233: Risk Control:\n",
      "Duplicate text found in row 234: For each risk, whether marked in green, yellow or red, Risk Control measures should be taken in order to reduce the severity of the harm or reduce the probability of its occurrence.\n",
      "Duplicate text found in row 235: The risk control measures should be one or more of the following options in the priority order listed:\n",
      "Duplicate text found in row 236: Inherent safety by design\n",
      "Duplicate text found in row 237: Protective measures in the product itself or in the manufacturing process.\n",
      "Duplicate text found in row 238: Information for safety\n",
      "Duplicate text found in row 239: Risk Control includes defining the measures to be taken in order to reduce the risks, Implementation of the risk control measures and verification of their implementation and their effectiveness, Residual Risk Evaluation after the Implementation. If measures are not practical Risk to Benefit Analysis should be made in order to demonstrate whether the products` benefits outweigh the residual risk. Risks arising from the risk control measures should be identified as well.\n",
      "Duplicate text found in row 240: At the end of the risk control measures, the Acceptability of the Overall Residual Risk is to be documented. \n",
      "Duplicate text found in row 241: Production & Post-production Information:\n",
      "Duplicate text found in row 242: After the end of the development phase, for each family of products, the risks should be reviewed according to information gained from the production of the device and afterwards information after the device is being sent to customers (customers' feedback and satisfaction, complaints, information from users, operators etc.). This information shall be evaluated to identify any unrecognized hazards and hazardous situations and to evaluate acceptability of risks that were identified previously.\n",
      "Duplicate text found in row 243: Verification plan\n",
      "Duplicate text found in row 244: After each important phase during product lifecycle a risk review meeting is to be performed (Initial risk review meeting: after Design Input).\n",
      "Duplicate text found in row 245: The Risk Analysis, Evaluation and Control activities are to be initially identified by a review meeting attending represents of all relevant departments (R&D, Manufacturing Eng, QA, Marketing, production etc. including someone not directly involved in the project or product).\n",
      "Duplicate text found in row 246: Reviews in order to verify that mitigation activities were performed and assessment of their effectiveness are to be performed by the person in charge of risk management from QA and the project manager.\n",
      "Duplicate text found in row 247: Overall residual risks acceptability and Risk to benefit analysis is also to be performed by QA and project manager.\n",
      "Duplicate text found in row 248: Other risk reviews in order to view the pre-identified hazards, risks, their evaluations and their relevance and to identify new hazards will be performed in a risk review meeting with representatives of all relevant departments.\n",
      "Duplicate text found in row 249: Allocation of responsibilities:\n",
      "Duplicate text found in row 250: Responsibility for assuring that the risk management activities are done is by the Project Manager.\n",
      "Duplicate text found in row 251: Person In charge for Risk Management activities execution: Quality Engineer in R&D.\n",
      "Duplicate text found in row 252: Responsibility of assuring that Risk Control activities are done as indicated in the Risk Management File is by the project manager.\n",
      "Duplicate text found in row 253: Risk Control measures are to be performed as indicated in the Risk Management File by the people mentioned there.\n",
      "Duplicate text found in row 254: Responsibility for Production & Post Production Information gathering & analyzing is Quality Engineer in R&D.\n",
      "Duplicate text found in row 255: Documenting Risk Management Process\n",
      "Duplicate text found in row 256: The Risk Management Process will be documented in the product's Design History File (DHF).  It will be according to the format specified in Appendix 5 of SOP#3-01-21. The risk management file will be managed as a controlled document, revised with the progression of the risk management process and all its revisions will be kept for process tracking in the design history file.\n",
      "Duplicate text found in row 257: Risk general management documents related to production and post production stages will be documented separately afterwards in \"Risk Management\" folder at the EPDM system.\n",
      "Duplicate text found in row 258: Summary\n",
      "Duplicate text found in row 259: This document outlines the risk management activities for all DPT modification projects. It determines the scales of rating them and the acceptance criteria. It also determines the means of reviewing and verifying them and the responsibilities. The product lifecycle stages in which this plan is applicable are as described in the scope.\n",
      "Duplicate text found in row 260: Document Revision Control:\n",
      "Duplicate text found in row 261: Revision History Tracking: Date: Revision 0- first release 19-Nov-2008 Revision A - Overall review and updates 30-Dec-2014 Revision B - Updating document format. Adding definitions of ALARP and AFAP to section 3. Updating Risk evaluation definitions in section 4.1.2.according to the new version of annexes 5, 7 and 8 of SOP 3-01-21. Adding guidance on severity rating; Adding clarification regarding the risk control (should be performed for all risks) and Updating location of general risk documents (in the EPDM system). 12-Jan-2017\n",
      "Duplicate text found in row 262: Review and approval:\n",
      "Duplicate text found in row 263: Written by: Name Date Signature QA Eng. - - -\n",
      "Duplicate text found in row 264: Reviewed & Approved by: Name Date Signature R&D Director /VP - - - VP of QA & RA/ QA Manager R&D - - -\n",
      "Duplicate text found in row 265: 3-01-21  SOP 4  Appendix Appendix status - released Revision  5 Valid from ‏25/12/2016 Product/s name Closed Stopcock & MRVLS Document status Under Edit Author - Title Revision B Risk Management Plan Release Date - Document# Doc-075342 Page 9 of 9\n",
      "Duplicate text found in row 266: Company: Elcam Medical\n",
      "Duplicate text found in row 267: Product Description:\n",
      "Duplicate text found in row 268: Elcam Closed Swabable Stopcocks (CSTP) and Minimal Residual Volume Luer-activated Swabable-stopcock (MRVLS) stopcocks are indicated for fluid flow directional control and for providing access port(s) for administration of solutions. Typical uses include pressure monitoring, intravenous fluid administration and transfusion.\n",
      "Duplicate text found in row 269: The Closed Swabable Stopcock includes an addition of a component that\n",
      "Duplicate text found in row 270: functions as a closed luer-activated valve.\n",
      "Duplicate text found in row 271: The MRVLS feature, is an additional option that can be added to the Closed Swabable\n",
      "Duplicate text found in row 272: Stopcock and provides a stopcock with a minimal residual volume.\n",
      "Duplicate text found in row 273: This Risk management plan covers all risk management activities required for CSTP and MRVLS projects as well as their design change projects.\n",
      "Duplicate text found in row 274: Their lifecycle stages are divided to:\n",
      "Duplicate text found in row 275: project initiation\n",
      "Duplicate text found in row 276: Design Planning\n",
      "Duplicate text found in row 277: Design Input\n",
      "Duplicate text found in row 278: Design Output\n",
      "Duplicate text found in row 279: Design Verification & Validation\n",
      "Duplicate text found in row 280: Process Validation\n",
      "Duplicate text found in row 281: Transfer to production\n",
      "Duplicate text found in row 282: Production & Post marketing\n",
      "Duplicate text found in row 283: First Risk review meeting shall be performed after Design Input and before Design V&V. Risk Management activities are categorized as Design Review Activities along the project\n",
      "Duplicate text found in row 284: Purpose:\n",
      "Duplicate text found in row 285: The purpose of this document is planning the risk management process for the Closed Stopcock and MRVLS family of products.\n",
      "Duplicate text found in row 286: Definitions:\n",
      "Duplicate text found in row 287: FMEA: Failure Mode and Effect Analysis.\n",
      "Duplicate text found in row 288: Harm: physical injury or damage to the health of people, or damage to property or the environment.\n",
      "Duplicate text found in row 289: Hazard: potential source of harm. \n",
      "Duplicate text found in row 290: Hazardous situation: circumstances in which people, property, or the environment are exposed to one or more hazard(s).\n",
      "Duplicate text found in row 291: Risk: combination of the probability of occurrence of harm and the severity of that harm.\n",
      "Duplicate text found in row 292: RPN: Risk Priority number, Multiply of Severity*Probability*Detectability.\n",
      "Duplicate text found in row 293: ALARP:  As Low As Reasonably Possible.\n",
      "Duplicate text found in row 294: AFAP:  As Far as Possible.\n",
      "Duplicate text found in row 295: Method:\n",
      "Duplicate text found in row 296: 4.1. Risk Management Process description:\n",
      "Duplicate text found in row 297: Risk Management process will be performed as required by ISO 14971:2007 and BS EN ISO 14971:2012, (\"Medical Devices – Application of risk management to medical devices\") and in accordance with Elcam's SOP# 03-01-21.\n",
      "Duplicate text found in row 298: The process will include Risk Analysis, Risk Evaluation and Risk Control and at the end of the process also Production & Post Production information.\n",
      "Duplicate text found in row 299: (The method for risk analysis and evaluation to be used is mainly FMEA (Fail Mode & Effect Analysis). Other techniques will be used as well when needed. \n",
      "Duplicate text found in row 300: The emphasis will be on risks primarily to the patient, but also to the operator, other persons, other equipment and the environment occurs during the product shelf life and/or in-use life. Risks which effect Elcam's image or Elcam's manufacturing facilities that do not affect product's safety or performance are not included within this Risk Management Process.\n",
      "Duplicate text found in row 301: 4.1.1. Risk Analysis:\n",
      "Duplicate text found in row 302: First step is listing the intended use or purpose of the product and its characteristics related to its safety. \n",
      "Duplicate text found in row 303: Then, identifying the known or foreseeable hazards and hazardous situations in normal and fault conditions, their causes and estimating the risks for each hazardous situation. This identification will initially be performed by a review meeting after design Input phase, after establishing the Device Requirements and the Product Specifications. \n",
      "Duplicate text found in row 304: 4.1.2. Risk Evaluation:\n",
      "Duplicate text found in row 305: The identified hazardous situations are evaluated for their risk probability of occurrence (P), severity (S) and detectability (D) according to the scales described below. Afterwards the RPN number is calculated by multiplying the ratings for each hazard and the acceptability is determined according to the acceptance criteria. \n",
      "Duplicate text found in row 306: Each parameter (P, S, or D) will be analyzed in order to rank and estimate the risk: \n",
      "Duplicate text found in row 307: Probability of occurrence (P):  \n",
      "Duplicate text found in row 308: Value Probability for occurrence Verbal description for probability 1 Less than 1 in 1,000,000 Evidence that will not occur 2 1:100,000 - 1:1,000,000 Low probability, rare occurrence 4 1:100,000 - 1:10,000 Will occur several times 6 1:100 - 1:10,000 Will occur several times 8 More than 1:100 High probability, likely to occur frequently\n",
      "Duplicate text found in row 309: Degree of Severity (S): \n",
      "Duplicate text found in row 310: S Rating Severity Severity to Patient/User Severity to Elcam Severity to Manufacture 1 Minor All is fine up to small discomfort, minor damage in performance. All is fine up to deviations in spec border. Small effect on equipment or product, a few production hours loss. 2 Medium Degradation in performance without harm. Damage to image, do not meet spec. Degradation in equipment or its operation small effect on product in non-functional characters, a few days loss. 4 Severe The part does not function but does not cause harm. Need to replace parts, severe impact to image, will not meet fundamental characteristic in spec. Medium degradation in equipment or its operation affecting product in non-functional characters, two-three weeks loss. 6 Severe - critical The product does not function and causes injury or condition requiring medical treatment. Severe impact to image, product will not meet the requirements of spec, market loss. High deterioration in equipment or its operation severely affecting production or product functionality, several week losses. 8 Critical Severe harm to patient: death, irreversible injury or condition or long term medical aid. Low suit, market loss. Severe damage to equipment, not being able to produce at all or producing non-functional products, loss of more than month and a half.\n",
      "Duplicate text found in row 311: Rate according to severity to patient/user or their environment. If the risk has an effect on several fields (patient/user and/or Elcam and/or Manufacture) rate according to the worst of all.\n",
      "Duplicate text found in row 312: Degree of Detectability (D): \n",
      "Duplicate text found in row 313: D Rating Defect Detection 1 Defect, if occurred, will always be detected at Elcam during production. 2 Defect, if occurred, will occasionally be detected at Elcam during production. 3 Defects, if occurred, will rarely be detected at Elcam or Will be detected by customer (not end user). 4 Defects, if occurred, will not be detected at Elcam. It will always be detected by the end user.\n",
      "Duplicate text found in row 314: RPN calculation:\n",
      "Duplicate text found in row 315: The calculation of the Risk Priority Number (RPN) is done by multiplying the risk analysis values:            (S x P) or (S x P x D).\n",
      "Duplicate text found in row 316: According to the calculated RPN value the priority for mitigation is determined (Risk Priority Level). \n",
      "Duplicate text found in row 317: Risk Priority Levels:\n",
      "Duplicate text found in row 318: (S*P) value Color Risk priority Level (S*P)≤8 (Green) Low 8<(S*P)<32 (Yellow) Medium (ALARP/AFAP*) 32≤(S*P) (Red) High\n",
      "Duplicate text found in row 319: Or\n",
      "Duplicate text found in row 320: (S*P*D) value Color Risk Priority Level (S*P*D)≤8 (Green) Low 8<(S*P*D)≤32 (Yellow) Medium (ALARP/AFAP*) 32<(S*P*D) (Red) High\n",
      "Duplicate text found in row 321: Green area – Low rated risks.\n",
      "Duplicate text found in row 322: Yellow area – Medium rated risks. \n",
      "Duplicate text found in row 323: Risks in the ALARP/AFAP area (ALARP is according to definition of ISO 14971:2007 AFAP is according to definition in BS EN ISO 14971:2012). Acceptable but require additional controls and monitoring. There should be actions to reduce them further and they require periodical review.\n",
      "Duplicate text found in row 324: Red area – High rated risk, additional actions should be taken to reduce this risk. \n",
      "Duplicate text found in row 325: 4.1.3. Risk Control:\n",
      "Duplicate text found in row 326: For each risk, whether marked in green, yellow or red, Risk Control measures should be taken in order to reduce the severity of the harm or reduce the probability of its occurrence.\n",
      "Duplicate text found in row 327: The risk control measures should be one or more of the following options in the priority order listed:\n",
      "Duplicate text found in row 328: Inherent safety by design\n",
      "Duplicate text found in row 329: Protective measures in the product itself or in the manufacturing process.\n",
      "Duplicate text found in row 330: Information for safety\n",
      "Duplicate text found in row 331: Risk Control includes defining the measures to be taken in order to reduce the risks, Implementation of the risk control measures and verification of their implementation and their effectiveness, Residual Risk Evaluation after the Implementation. If measures are not practical Risk to Benefit Analysis should be made in order to demonstrate whether the products` benefits outweigh the residual risk. Risks arising from the risk control measures should be identified as well.\n",
      "Duplicate text found in row 332: At the end of the risk control measures, the Acceptability of the Overall Residual Risk is to be documented. \n",
      "Duplicate text found in row 333: 4.1.4. Production & Post-production Information:\n",
      "Duplicate text found in row 334: After the end of the development phase, for each family of products, the risks should be reviewed according to information gained from the production of the device and afterwards information after the device is being sent to customers (customers' feedback and satisfaction, complaints, information from users, operators etc.). This information shall be evaluated to identify any unrecognized hazards and hazardous situations and to evaluate acceptability of risks that were identified previously.\n",
      "Duplicate text found in row 335: 4.2. Verification plan\n",
      "Duplicate text found in row 336: After each important phase during product lifecycle a risk review meeting is to be performed (Initial risk review meeting: after Design Input).\n",
      "Duplicate text found in row 337: The Risk Analysis, Evaluation and Control activities are to be initially identified by a review meeting attending represents of all relevant departments (R&D, Manufacturing Eng, QA, Marketing, production etc. including someone not directly involved in the project or product).\n",
      "Duplicate text found in row 338: Reviews in order to verify that mitigation activities were performed and assessment of their effectiveness are to be performed by the person in charge of risk management from QA and the project manager.\n",
      "Duplicate text found in row 339: Overall residual risks acceptability and Risk to benefit analysis is also to be performed by QA and project manager.\n",
      "Duplicate text found in row 340: Other risk reviews in order to view the pre-identified hazards, risks, their evaluations and their relevance and to identify new hazards will be performed in a risk review meeting with representatives of all relevant departments.\n",
      "Duplicate text found in row 341: 4.3. Allocation of responsibilities:\n",
      "Duplicate text found in row 342: 4.3.1. Responsibility for assuring that the risk management activities are done is by the Project Manager.\n",
      "Duplicate text found in row 343: 4.3.2. Person In charge for Risk Management activities execution: Quality Engineer in R&D.\n",
      "Duplicate text found in row 344: 4.3.3. Responsibility of assuring that Risk Control activities are done as indicated in the Risk Management File is by the project manager.\n",
      "Duplicate text found in row 345: 4.3.4. Risk Control measures are to be performed as indicated in the Risk Management File by the people mentioned there.\n",
      "Duplicate text found in row 346: 4.3.5. Responsibility for Production & Post Production Information gathering & analyzing is Quality Engineer in R&D.\n",
      "Duplicate text found in row 347: Documenting Risk Management Process\n",
      "Duplicate text found in row 348: The Risk Management Process will be documented in the product's Design History File (DHF).  It will be according to the format specified in Appendix 5 of SOP#3-01-21. The risk management file will be managed as a controlled document, revised with the progression of the risk management process and all its revisions will be kept for process tracking in the design history file.\n",
      "Duplicate text found in row 349: Risk general management documents related to production and post production stages will be documented separately afterwards in \"Risk Management\" folder at the EPDM system.\n",
      "Duplicate text found in row 350: Summary\n",
      "Duplicate text found in row 351: This document outlines the risk management activities for CSTP and MRVLS family of products. It determines the scales of rating them and the acceptance criteria. It also determines the means of reviewing and verifying them and the responsibilities. The product lifecycle stages in which this plan is applicable are as described in the scope.\n",
      "Duplicate text found in row 352: Document Revision Control:\n",
      "Duplicate text found in row 353: Revision History Tracking: Date: Revision 0- first version 5-July-2012 Revision A – update of referenced standards and definition of ALARP/AFAP. 16-Mar-2014 Revision B – Updating document format; Moving the definitions of ALARP and AFAP to section 3; Updating Risk evaluation definitions in section 4.1.2. according to the new version of annexes 5, 7 and 8 of SOP 3-01-21.; Adding guidance on severity rating; Adding clarification regarding the risk control (should be performed for all risks); Updating location of general risk documents (in the EPDM system); and Correcting duplicate of sections 4.3 \"Responsibilities\" and 4.3. \"Allocation of responsibilities\". 27-Dec-2016\n",
      "Duplicate text found in row 354: Review and approval:\n",
      "Duplicate text found in row 355: Written by: Name Date Signature QA Eng. - - -\n",
      "Duplicate text found in row 356: Reviewed & Approved by: Name Date Signature R&D Director /VP - - - VP of QA & RA/ QA Manager R&D - - -\n",
      "Duplicate text found in row 357: SOP 3-01-21 4  Appendix Appendix status - released Revision  7 Valid from ‏20/04/2017 Product/s name Closed Stopcock & MRVLS Document status Under Edit Author - Title Revision C Risk Management Plan Release Date - Document# Doc-081935 Page 8 of 8\n",
      "Duplicate text found in row 358: Company: Elcam Medical\n",
      "Duplicate text found in row 359: Product Description:\n",
      "Duplicate text found in row 360: Elcam Closed Swabable Stopcocks (CSTP) and Minimal Residual Volume Luer-activated Swabable-stopcock (MRVLS) stopcocks are indicated for fluid flow directional control and for providing access port(s) for administration of solutions. Typical uses include pressure monitoring, intravenous fluid administration and transfusion.\n",
      "Duplicate text found in row 361: The Closed Swabable Stopcock includes an addition of a component that\n",
      "Duplicate text found in row 362: functions as a closed luer-activated valve.\n",
      "Duplicate text found in row 363: The MRVLS feature, is an additional option that can be added to the Closed Swabable\n",
      "Duplicate text found in row 364: Stopcock and provides a stopcock with a minimal residual volume.\n",
      "Duplicate text found in row 365: This Risk management plan covers all risk management activities required for CSTP and MRVLS projects as well as their design change projects.\n",
      "Duplicate text found in row 366: Their lifecycle stages are divided to:\n",
      "Duplicate text found in row 367: project initiation\n",
      "Duplicate text found in row 368: Design Planning\n",
      "Duplicate text found in row 369: Design Input\n",
      "Duplicate text found in row 370: Design Output\n",
      "Duplicate text found in row 371: Design Verification & Validation\n",
      "Duplicate text found in row 372: Process Validation\n",
      "Duplicate text found in row 373: Transfer to production\n",
      "Duplicate text found in row 374: Production & Post marketing\n",
      "Duplicate text found in row 375: First Risk review meeting shall be performed after Design Input and before Design V&V. Risk Management activities are categorized as Design Review Activities along the project\n",
      "Duplicate text found in row 376: Purpose:\n",
      "Duplicate text found in row 377: The purpose of this document is planning the risk management process for the Closed Stopcock and MRVLS family of products.\n",
      "Duplicate text found in row 378: Definitions:\n",
      "Duplicate text found in row 379: FMEA: Failure Mode and Effect Analysis.\n",
      "Duplicate text found in row 380: Harm: physical injury or damage to the health of people, or damage to property or the environment.\n",
      "Duplicate text found in row 381: Hazard: potential source of harm. \n",
      "Duplicate text found in row 382: Hazardous situation: circumstances in which people, property, or the environment are exposed to one or more hazard(s).\n",
      "Duplicate text found in row 383: Risk: combination of the probability of occurrence of harm and the severity of that harm.\n",
      "Duplicate text found in row 384: RPN: Risk Priority number, Multiply of Severity*Probability*Detectability.\n",
      "Duplicate text found in row 385: ALARP:  As Low As Reasonably Possible.\n",
      "Duplicate text found in row 386: AFAP:  As Far as Possible.\n",
      "Duplicate text found in row 387: Method:\n",
      "Duplicate text found in row 388: 4.1. Risk Management Process description:\n",
      "Duplicate text found in row 389: Risk Management process will be performed as required by ISO 14971:2007 and BS EN ISO 14971:2012, (\"Medical Devices – Application of risk management to medical devices\") and in accordance with Elcam's SOP# 03-01-21.\n",
      "Duplicate text found in row 390: The process will include Risk Analysis, Risk Evaluation and Risk Control and at the end of the process also Production & Post Production information.\n",
      "Duplicate text found in row 391: (The method for risk analysis and evaluation to be used is mainly FMEA (Fail Mode & Effect Analysis). Other techniques will be used as well when needed. \n",
      "Duplicate text found in row 392: The emphasis will be on risks primarily to the patient, but also to the operator, other persons, other equipment and the environment occurs during the product shelf life and/or in-use life. Risks which effect Elcam's image or Elcam's manufacturing facilities that do not affect product's safety or performance are not included within this Risk Management Process.\n",
      "Duplicate text found in row 393: 4.1.1. Risk Analysis:\n",
      "Duplicate text found in row 394: First step is listing the intended use or purpose of the product and its characteristics related to its safety. \n",
      "Duplicate text found in row 395: Then, identifying the known or foreseeable hazards and hazardous situations in normal and fault conditions, their causes and estimating the risks for each hazardous situation. This identification will initially be performed by a review meeting after design Input phase, after establishing the Device Requirements and the Product Specifications. \n",
      "Duplicate text found in row 396: 4.1.2. Risk Evaluation:\n",
      "Duplicate text found in row 397: The identified hazardous situations are evaluated for their risk probability of occurrence (P), severity (S) and detectability (D) according to the scales described below. Afterwards the RPN number is calculated by multiplying the ratings for each hazard and the acceptability is determined according to the acceptance criteria. \n",
      "Duplicate text found in row 398: Each parameter (P, S, or D) will be analyzed in order to rank and estimate the risk: \n",
      "Duplicate text found in row 399: Probability of occurrence (P):  \n",
      "Duplicate text found in row 400: Value Probability for occurrence Verbal description for probability 1 Less than 1 in 1,000,000 Evidence that will not occur 2 1:10,000 - 1:1,000,000 Low probability, rare occurrence 4 1:1,000 - 1:10,000 Will occur several times 6 1:100 - 1:1,000 Will occur several times, often 8 More than 1:100 High probability, likely to occur frequently\n",
      "Duplicate text found in row 401: Degree of Severity (S): \n",
      "Duplicate text found in row 402: S Rating Severity Severity to Patient/User Severity to Elcam Severity to Manufacture 1 Minor All is fine up to small discomfort, minor damage in performance. All is fine up to deviations in spec border. Small effect on equipment or product, a few production hours loss. 2 Medium Degradation in performance without harm. Damage to image, do not meet spec. Degradation in equipment or its operation small effect on product in non-functional characters, a few days loss. 4 Severe The part does not function but does not cause harm. Need to replace parts, severe impact to image, will not meet fundamental characteristic in spec. Medium degradation in equipment or its operation affecting product in non-functional characters, two-three weeks loss. 6 Severe - critical The product does not function and causes injury or condition requiring medical treatment. Severe impact to image, product will not meet the requirements of spec, market loss. High deterioration in equipment or its operation severely affecting production or product functionality, several week losses. 8 Critical Severe harm to patient: death, irreversible injury or condition or long term medical aid. Low suit, market loss. Severe damage to equipment, not being able to produce at all or producing non-functional products, loss of more than month and a half.\n",
      "Duplicate text found in row 403: Rate according to severity to patient/user or their environment. If the risk has an effect on several fields (patient/user and/or Elcam and/or Manufacture) rate according to the worst of all.\n",
      "Duplicate text found in row 404: Degree of Detectability (D) – Relevant mainly to Process risks: \n",
      "Duplicate text found in row 405: D Rating Defect Detection 1 Defect, if occurred, will always be detected at Elcam during production. 2 Defect, if occurred, will occasionally be detected at Elcam during production. 3 Defects, if occurred, will rarely be detected at Elcam or Will be detected by customer (not end user). 4 Defects, if occurred, will not be detected at Elcam. It will always be detected by the end user.\n",
      "Duplicate text found in row 406: RPN calculation:\n",
      "Duplicate text found in row 407: The calculation of the Risk Priority Number (RPN) is done by multiplying the risk values:         (S x P) or (S x P x D).\n",
      "Duplicate text found in row 408: According to the calculated RPN value the priority for mitigation is determined (Risk Priority Level). \n",
      "Duplicate text found in row 409: Risk Priority Levels:\n",
      "Duplicate text found in row 410: (S*P) value Color Risk priority Level (S*P)≤8 (Green) Low 8<(S*P) ≤32 (Yellow) Medium (ALARP/AFAP*) 32< (S*P) (Red) High\n",
      "Duplicate text found in row 411: Or\n",
      "Duplicate text found in row 412: (S*P*D) value Color Risk Priority Level (S*P*D)≤8 (Green) Low 8<(S*P*D)≤32 (Yellow) Medium (ALARP/AFAP*) 32<(S*P*D) (Red) High\n",
      "Duplicate text found in row 413: Green area – Low rated risks.\n",
      "Duplicate text found in row 414: Yellow area – Medium rated risks. \n",
      "Duplicate text found in row 415: Risks in the ALARP/AFAP area (ALARP is according to definition of ISO 14971:2007 AFAP is according to definition in BS EN ISO 14971:2012). Acceptable but require additional controls and monitoring. There should be actions to reduce them further and they require periodical review.\n",
      "Duplicate text found in row 416: Red area – High rated risk, additional actions should be taken to reduce this risk. \n",
      "Duplicate text found in row 417: 4.1.3. Risk Control:\n",
      "Duplicate text found in row 418: For each risk, whether marked in green, yellow or red, Risk Control measures should be taken in order to reduce the severity of the harm or reduce the probability of its occurrence.\n",
      "Duplicate text found in row 419: The risk control measures should be one or more of the following options in the priority order listed:\n",
      "Duplicate text found in row 420: Inherent safety by design\n",
      "Duplicate text found in row 421: Protective measures in the product itself or in the manufacturing process.\n",
      "Duplicate text found in row 422: Information for safety\n",
      "Duplicate text found in row 423: Risk Control includes defining the measures to be taken in order to reduce the risks, Implementation of the risk control measures and verification of their implementation and their effectiveness, Residual Risk Evaluation after the Implementation. If measures are not practical Risk to Benefit Analysis should be made in order to demonstrate whether the products` benefits outweigh the residual risk. Risks arising from the risk control measures should be identified as well.\n",
      "Duplicate text found in row 424: At the end of the risk control measures, the Acceptability of the Overall Residual Risk is to be documented. \n",
      "Duplicate text found in row 425: 4.1.4. Production & Post-production Information:\n",
      "Duplicate text found in row 426: After the end of the development phase, for each family of products, the risks should be reviewed according to information gained from the production of the device and afterwards information after the device is being sent to customers (customers' feedback and satisfaction, complaints, information from users, operators etc.). This information shall be evaluated to identify any unrecognized hazards and hazardous situations and to evaluate acceptability of risks that were identified previously.\n",
      "Duplicate text found in row 427: 4.2. Verification plan\n",
      "Duplicate text found in row 428: After each important phase during product lifecycle a risk review meeting is to be performed (Initial risk review meeting: after Design Input).\n",
      "Duplicate text found in row 429: The Risk Analysis, Evaluation and Control activities are to be initially identified by a review meeting attending represents of all relevant departments (R&D, Manufacturing Eng, QA, Marketing, production etc. including someone not directly involved in the project or product).\n",
      "Duplicate text found in row 430: Reviews in order to verify that mitigation activities were performed and assessment of their effectiveness are to be performed by the person in charge of risk management from QA and the project manager.\n",
      "Duplicate text found in row 431: Overall residual risks acceptability and Risk to benefit analysis is also to be performed by QA and project manager.\n",
      "Duplicate text found in row 432: Other risk reviews in order to view the pre-identified hazards, risks, their evaluations and their relevance and to identify new hazards will be performed in a risk review meeting with representatives of all relevant departments.\n",
      "Duplicate text found in row 433: 4.3. Allocation of responsibilities:\n",
      "Duplicate text found in row 434: 4.3.1. Responsibility for assuring that the risk management activities are done is by the Project Manager.\n",
      "Duplicate text found in row 435: 4.3.2. Person In charge for Risk Management activities execution: Quality Engineer in R&D.\n",
      "Duplicate text found in row 436: 4.3.3. Responsibility of assuring that Risk Control activities are done as indicated in the Risk Management File is by the project manager.\n",
      "Duplicate text found in row 437: 4.3.4. Risk Control measures are to be performed as indicated in the Risk Management File by the people mentioned there.\n",
      "Duplicate text found in row 438: 4.3.5. Responsibility for Production & Post Production Information gathering & analyzing is Quality Engineer in R&D.\n",
      "Duplicate text found in row 439: Documenting Risk Management Process\n",
      "Duplicate text found in row 440: The Risk Management Process will be documented in the product's Design History File (DHF).  It will be according to the format specified in Appendix 5 or 8 of SOP#3-01-21. The risk management file will be managed as a controlled document, revised with the progression of the risk management process and all its revisions will be kept for process tracking in the design history file.\n",
      "Duplicate text found in row 441: General Risk management documents (for family of products) related to production and post production stages will be documented separately afterwards in \"Risk Management\" folder at the EPDM system and using appendix 7 of SOP 3-01-21. \n",
      "Duplicate text found in row 442: Summary\n",
      "Duplicate text found in row 443: This document outlines the risk management activities for the CSTP and MRVLS family of products. It determines the scales of rating them and the Risk Priority Levels. It also determines the means of reviewing and verifying them and the responsibilities. The product lifecycle stages in which this plan is applicable are as described in the scope.\n",
      "Duplicate text found in row 444: Document Revision Control:\n",
      "Duplicate text found in row 445: Revision History Tracking: Date: Revision 0- first version 5-July-2012 Revision A – update of referenced standards and definition of ALARP/AFAP. 16-Mar-2014 Revision B – Updating document format; Moving the definitions of ALARP and AFAP to section 3; Updating Risk evaluation definitions in section 4.1.2. according to the new version of annexes 5, 7 and 8 of SOP 3-01-21.; Adding guidance on severity rating; Adding clarification regarding the risk control (should be performed for all risks); Updating location of general risk documents (in the EPDM system); and Correcting duplicate of sections 4.3 \"Responsibilities\" and 4.3. \"Allocation of responsibilities\". 27-Dec-2016 Revision C – Correcting Probability scales and Risk Priority Levels according latest version of Appendix 5, 7 and 8 of SOP 3-01-21. Adding guidance for using appendix 5, 7 and 8 of SOP 3-01-21 to \"Documenting Risk Management Process\" section. 17-May-2017\n",
      "Duplicate text found in row 446: Review and approval:\n",
      "Duplicate text found in row 447: Written by: Name Date Signature QA Eng. - - -\n",
      "Duplicate text found in row 448: Reviewed & Approved by: Name Date Signature Chief Technology Officer /R&D Manager - - - Chief Quality & RA Officer/ QA Manager R&D - - -\n"
     ]
    }
   ],
   "source": [
    "#iterate over the rows of the DataFrame and check if there is any duplicate text\n",
    "for index, row in df.iterrows():\n",
    "    if df['text'].duplicated().any():\n",
    "        print(f\"Duplicate text found in row {index}: {row['text']}\")\n",
    "    else:\n",
    "        print(f\"No duplicate text found in row {index}: {row['text']}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Help on method partition in module unstructured_client.general:\n",
      "\n",
      "partition(*, request: Union[unstructured_client.models.operations.partition.PartitionRequest, unstructured_client.models.operations.partition.PartitionRequestTypedDict], retries: OptionalNullable[unstructured_client.utils.retries.RetryConfig] = Unset(), server_url: Optional[str] = None, timeout_ms: Optional[int] = None, accept_header_override: Optional[unstructured_client.general.PartitionAcceptEnum] = None, http_headers: Optional[Mapping[str, str]] = None) -> unstructured_client.models.operations.partition.PartitionResponse method of unstructured_client.general.General instance\n",
      "    Summary\n",
      "\n",
      "    Description\n",
      "\n",
      "    :param request: The request object to send.\n",
      "    :param retries: Override the default retry configuration for this method\n",
      "    :param server_url: Override the default server URL for this method\n",
      "    :param timeout_ms: Override the default request timeout configuration for this method in milliseconds\n",
      "    :param accept_header_override: Override the default accept header for this method\n",
      "    :param http_headers: Additional headers to set or replace on requests.\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import unstructured_client\n",
    "client=unstructured_client.UnstructuredClient(\n",
    "    api_key_auth=os.getenv(\"UNSTRUCTURED_API_KEY\")\n",
    ")\n",
    "\n",
    "# # Example document path - adjust as needed\n",
    "# document_path = \"path/to/your/document.pdf\"  # Change this to your \n",
    "# document path\n",
    "\n",
    "# # Extract elements from document\n",
    "# elements = partition(document_path)\n",
    "\n",
    "# # Convert elements to a pandas DataFrame\n",
    "# rows = []\n",
    "# for element in elements:\n",
    "#     # Extract common properties\n",
    "#     element_data = {\n",
    "#         'type': element.category,\n",
    "#         'element_id': element.id,\n",
    "#         'text': element.text\n",
    "#     }\n",
    "\n",
    "#     # Add metadata as separate columns\n",
    "#     if hasattr(element, 'metadata'):\n",
    "#         metadata = element.metadata.to_dict() if\n",
    "# hasattr(element.metadata, 'to_dict') else element.metadata\n",
    "\n",
    "#         # Add common metadata fields \n",
    "#         for field in ['filename', 'file_directory', 'last_modified',\n",
    "# 'filetype', 'page_number', 'parent_id', 'languages']:\n",
    "#             element_data[field] = metadata.get(field, None)\n",
    "\n",
    "#     rows.append(element_data)\n",
    "\n",
    "# # Create DataFrame\n",
    "# df = pd.DataFrame(rows)\n",
    "\n",
    "# # Example usage:\n",
    "# print(f\"Created DataFrame with {len(df)} elements\")\n",
    "# print(df.head())\n",
    "\n",
    "# # Optional: Filter to specific element types\n",
    "# narrative_text = df[df['type'] == 'NarrativeText']\n",
    "# tables = df[df['type'] == 'Table']"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
